Stacks & FormulasResearch OnlyNot For Human Consumption

Glow Stack

GHK-Cu + BPC-157 + TB-500 Hybrid · Noventra Glow Stack

Triple-compound skin and systemic repair stack - GHK-Cu's collagen and genomic repair paired with BPC-157 and TB-500's tissue healing.

MECHANISM OF ACTION

The Glow Stack adds GHK-Cu (copper tripeptide) to the Wolverine base (BPC-157 + TB-500). GHK-Cu contributes: collagen I, III, and elastin synthesis; decorin upregulation for extracellular matrix quality; antioxidant enzyme activation; and the genomic expression programme affecting >4000 repair and longevity genes. Combined with BPC-157 (angiogenesis, GI repair) and TB-500 (systemic cell migration, anti-inflammatory), the Glow Stack creates a comprehensive skin-regeneration, anti-ageing, and systemic repair protocol. GHK-Cu's skin effects are amplified by BPC-157's vascular bed development and TB-500's cellular migration signals.

RESEARCH APPLICATIONS

  • Skin collagen synthesis and anti-ageing
  • Comprehensive recovery + skin rejuvenation combined protocol
  • Post-aesthetic procedure healing acceleration
  • Extracellular matrix quality and dermal architecture
  • Systemic anti-inflammatory + skin repair

RESEARCH HIGHLIGHTS

Complementary Collagen + Vascular Mechanisms

GHK-Cu stimulates procollagen and elastin synthesis while BPC-157 promotes the capillary bed that nourishes healing skin - the combination addresses both structural protein production and vascular delivery.

Ref: Maquart et al. (GHK-Cu) + Hsieh et al. (BPC-157)

RESEARCH PROTOCOL NOTES

Typical blendGHK-Cu 50% + BPC-157 25% + TB-500 25% approximate ratio
Available formatsPen (Glow Stack Hybrid Pen 50mg - Noventra)
Skin contextGHK-Cu blue colour visible in reconstituted solution - normal

Chemical Identity

Storage & Stability

Same as GHK-Cu: maintain pH 6.0–6.5 to prevent copper dissociation. -20°C lyophilised. 2–8°C reconstituted, 21 days.

Regulatory Status

Combined research compound. Same regulatory considerations as each component - GHK-Cu (topical = cosmetic; injectable = research), BPC-157 and TB-500 (research compounds).